Delivery Order SPE2DR25D1053-SPE2DR26FT323
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This $14,592.57 firm fixed price delivery order has a completion date of December 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen...
- The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 tablets. This is a firm fixed-price delivery order with an ultimate completion date of December 8, 2025. The contract was not designated with any set-aside provision and was competitively awarded. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $41,540.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 units. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, valued at $14,592.57 for the supply of Vyndamax 61 mg capsule unit dose 30-count packages. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a $55,387.88 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages), with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Vyndamax 61 mg capsule unit dose 30-count packages. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 18, 2025, and represents a child order under a larger contract vehicle. The delivery is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on September 18, 2025, with completion scheduled for October 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packaging (30-count) on August 8, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vyndamax 61 mg capsule unit dose 30s, a pharmaceutical product for federal medical procurement needs. This competitively awarded, firm fixed price delivery order is not set-aside and is scheduled for completion by October 6, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT323Delivery Order
The Defense Logistics Agency awarded a $14,592.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packets (30 count) on October 27, 2025, with completion scheduled for November 18, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency and broader military healthcare supply chain requirements through AmerisourceBergen's extensive federal pharmaceutical distribution network. AmerisourceBergen operates under a significant $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) extending through December 2026, which serves as the foundational vehicle enabling the company to supply specialty medications, brand-name and generic pharmaceuticals, and related medical commodities to support military and veteran healthcare systems globally. The current award reflects the company's continued role as a critical pharmaceutical vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 10/27/25 |